エプロサルタンメシレートのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Eprosartan Mesylate Market Insights, Forecast to 2028

• レポートコード：QY2207C0299 • 出版社/出版日：QYResearch / 2022年7月15日 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のエプロサルタンメシレートの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にエプロサルタンメシレートの世界市場のxxx％を占める「200mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「高血圧診断」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のエプロサルタンメシレートの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのエプロサルタンメシレート市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのエプロサルタンメシレート市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 エプロサルタンメシレートのグローバル主要メーカーには、Abbott、Viatris (Mylan)、The United States Pharmacopeial Convention、Unichem Laboratories、Jubilant Genericsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 エプロサルタンメシレート市場は、種類と用途によって区分されます。世界のエプロサルタンメシレート市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 200mg、400mg 【用途別セグメント】 高血圧診断、心不全診断、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - エプロサルタンメシレート製品概要 - 種類別市場（200mg、400mg） - 用途別市場（高血圧診断、心不全診断、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のエプロサルタンメシレート販売量予測2017-2028 - 世界のエプロサルタンメシレート売上予測2017-2028 - エプロサルタンメシレートの地域別販売量 - エプロサルタンメシレートの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別エプロサルタンメシレート販売量 - 主要メーカー別エプロサルタンメシレート売上 - 主要メーカー別エプロサルタンメシレート価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（200mg、400mg） - エプロサルタンメシレートの種類別販売量 - エプロサルタンメシレートの種類別売上 - エプロサルタンメシレートの種類別価格 ・用途別市場規模（高血圧診断、心不全診断、その他） - エプロサルタンメシレートの用途別販売量 - エプロサルタンメシレートの用途別売上 - エプロサルタンメシレートの用途別価格 ・北米市場 - 北米のエプロサルタンメシレート市場規模（種類別、用途別） - 主要国別のエプロサルタンメシレート市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのエプロサルタンメシレート市場規模（種類別、用途別） - 主要国別のエプロサルタンメシレート市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のエプロサルタンメシレート市場規模（種類別、用途別） - 主要国別のエプロサルタンメシレート市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のエプロサルタンメシレート市場規模（種類別、用途別） - 主要国別のエプロサルタンメシレート市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのエプロサルタンメシレート市場規模（種類別、用途別） - 主要国別のエプロサルタンメシレート市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、Viatris (Mylan)、The United States Pharmacopeial Convention、Unichem Laboratories、Jubilant Generics ・産業チェーン及び販売チャネル分析 - エプロサルタンメシレートの産業チェーン分析 - エプロサルタンメシレートの原材料 - エプロサルタンメシレートの生産プロセス - エプロサルタンメシレートの販売及びマーケティング - エプロサルタンメシレートの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - エプロサルタンメシレートの産業動向 - エプロサルタンメシレートのマーケットドライバー - エプロサルタンメシレートの課題 - エプロサルタンメシレートの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Eprosartan Mesylate Market
Due to the COVID-19 pandemic, the global Eprosartan Mesylate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 200mg accounting for % of the Eprosartan Mesylate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hypertension Diagnosis segment is altered to an % CAGR throughout this forecast period.
China Eprosartan Mesylate market size is valued at US$ million in 2021, while the US and Europe Eprosartan Mesylate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Eprosartan Mesylate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Eprosartan Mesylate include Abbott, Viatris (Mylan), The United States Pharmacopeial Convention, Unichem Laboratories and Jubilant Generics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Eprosartan Mesylate capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Eprosartan Mesylate by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Eprosartan Mesylate Scope and Segment
Eprosartan Mesylate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Eprosartan Mesylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
200mg
400mg
Segment by Application
Hypertension Diagnosis
Heart Failure Diagnosis
Others
By Company
Abbott
Viatris (Mylan)
The United States Pharmacopeial Convention
Unichem Laboratories
Jubilant Generics
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Eprosartan Mesylate Product Introduction
1.2 Market by Type
1.2.1 Global Eprosartan Mesylate Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 200mg
1.2.3 400mg
1.3 Market by Application
1.3.1 Global Eprosartan Mesylate Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hypertension Diagnosis
1.3.3 Heart Failure Diagnosis
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Eprosartan Mesylate Production
2.1 Global Eprosartan Mesylate Production Capacity (2017-2028)
2.2 Global Eprosartan Mesylate Production by Region: 2017 VS 2021 VS 2028
2.3 Global Eprosartan Mesylate Production by Region
2.3.1 Global Eprosartan Mesylate Historic Production by Region (2017-2022)
2.3.2 Global Eprosartan Mesylate Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Eprosartan Mesylate Sales in Volume & Value Estimates and Forecasts
3.1 Global Eprosartan Mesylate Sales Estimates and Forecasts 2017-2028
3.2 Global Eprosartan Mesylate Revenue Estimates and Forecasts 2017-2028
3.3 Global Eprosartan Mesylate Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Eprosartan Mesylate Sales by Region
3.4.1 Global Eprosartan Mesylate Sales by Region (2017-2022)
3.4.2 Global Sales Eprosartan Mesylate by Region (2023-2028)
3.5 Global Eprosartan Mesylate Revenue by Region
3.5.1 Global Eprosartan Mesylate Revenue by Region (2017-2022)
3.5.2 Global Eprosartan Mesylate Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Eprosartan Mesylate Production Capacity by Manufacturers
4.2 Global Eprosartan Mesylate Sales by Manufacturers
4.2.1 Global Eprosartan Mesylate Sales by Manufacturers (2017-2022)
4.2.2 Global Eprosartan Mesylate Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Eprosartan Mesylate in 2021
4.3 Global Eprosartan Mesylate Revenue by Manufacturers
4.3.1 Global Eprosartan Mesylate Revenue by Manufacturers (2017-2022)
4.3.2 Global Eprosartan Mesylate Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Eprosartan Mesylate Revenue in 2021
4.4 Global Eprosartan Mesylate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Eprosartan Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Eprosartan Mesylate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Eprosartan Mesylate Sales by Type
5.1.1 Global Eprosartan Mesylate Historical Sales by Type (2017-2022)
5.1.2 Global Eprosartan Mesylate Forecasted Sales by Type (2023-2028)
5.1.3 Global Eprosartan Mesylate Sales Market Share by Type (2017-2028)
5.2 Global Eprosartan Mesylate Revenue by Type
5.2.1 Global Eprosartan Mesylate Historical Revenue by Type (2017-2022)
5.2.2 Global Eprosartan Mesylate Forecasted Revenue by Type (2023-2028)
5.2.3 Global Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
5.3 Global Eprosartan Mesylate Price by Type
5.3.1 Global Eprosartan Mesylate Price by Type (2017-2022)
5.3.2 Global Eprosartan Mesylate Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Eprosartan Mesylate Sales by Application
6.1.1 Global Eprosartan Mesylate Historical Sales by Application (2017-2022)
6.1.2 Global Eprosartan Mesylate Forecasted Sales by Application (2023-2028)
6.1.3 Global Eprosartan Mesylate Sales Market Share by Application (2017-2028)
6.2 Global Eprosartan Mesylate Revenue by Application
6.2.1 Global Eprosartan Mesylate Historical Revenue by Application (2017-2022)
6.2.2 Global Eprosartan Mesylate Forecasted Revenue by Application (2023-2028)
6.2.3 Global Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
6.3 Global Eprosartan Mesylate Price by Application
6.3.1 Global Eprosartan Mesylate Price by Application (2017-2022)
6.3.2 Global Eprosartan Mesylate Price Forecast by Application (2023-2028)
7 North America
7.1 North America Eprosartan Mesylate Market Size by Type
7.1.1 North America Eprosartan Mesylate Sales by Type (2017-2028)
7.1.2 North America Eprosartan Mesylate Revenue by Type (2017-2028)
7.2 North America Eprosartan Mesylate Market Size by Application
7.2.1 North America Eprosartan Mesylate Sales by Application (2017-2028)
7.2.2 North America Eprosartan Mesylate Revenue by Application (2017-2028)
7.3 North America Eprosartan Mesylate Sales by Country
7.3.1 North America Eprosartan Mesylate Sales by Country (2017-2028)
7.3.2 North America Eprosartan Mesylate Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Eprosartan Mesylate Market Size by Type
8.1.1 Europe Eprosartan Mesylate Sales by Type (2017-2028)
8.1.2 Europe Eprosartan Mesylate Revenue by Type (2017-2028)
8.2 Europe Eprosartan Mesylate Market Size by Application
8.2.1 Europe Eprosartan Mesylate Sales by Application (2017-2028)
8.2.2 Europe Eprosartan Mesylate Revenue by Application (2017-2028)
8.3 Europe Eprosartan Mesylate Sales by Country
8.3.1 Europe Eprosartan Mesylate Sales by Country (2017-2028)
8.3.2 Europe Eprosartan Mesylate Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Eprosartan Mesylate Market Size by Type
9.1.1 Asia Pacific Eprosartan Mesylate Sales by Type (2017-2028)
9.1.2 Asia Pacific Eprosartan Mesylate Revenue by Type (2017-2028)
9.2 Asia Pacific Eprosartan Mesylate Market Size by Application
9.2.1 Asia Pacific Eprosartan Mesylate Sales by Application (2017-2028)
9.2.2 Asia Pacific Eprosartan Mesylate Revenue by Application (2017-2028)
9.3 Asia Pacific Eprosartan Mesylate Sales by Region
9.3.1 Asia Pacific Eprosartan Mesylate Sales by Region (2017-2028)
9.3.2 Asia Pacific Eprosartan Mesylate Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Eprosartan Mesylate Market Size by Type
10.1.1 Latin America Eprosartan Mesylate Sales by Type (2017-2028)
10.1.2 Latin America Eprosartan Mesylate Revenue by Type (2017-2028)
10.2 Latin America Eprosartan Mesylate Market Size by Application
10.2.1 Latin America Eprosartan Mesylate Sales by Application (2017-2028)
10.2.2 Latin America Eprosartan Mesylate Revenue by Application (2017-2028)
10.3 Latin America Eprosartan Mesylate Sales by Country
10.3.1 Latin America Eprosartan Mesylate Sales by Country (2017-2028)
10.3.2 Latin America Eprosartan Mesylate Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Eprosartan Mesylate Market Size by Type
11.1.1 Middle East and Africa Eprosartan Mesylate Sales by Type (2017-2028)
11.1.2 Middle East and Africa Eprosartan Mesylate Revenue by Type (2017-2028)
11.2 Middle East and Africa Eprosartan Mesylate Market Size by Application
11.2.1 Middle East and Africa Eprosartan Mesylate Sales by Application (2017-2028)
11.2.2 Middle East and Africa Eprosartan Mesylate Revenue by Application (2017-2028)
11.3 Middle East and Africa Eprosartan Mesylate Sales by Country
11.3.1 Middle East and Africa Eprosartan Mesylate Sales by Country (2017-2028)
11.3.2 Middle East and Africa Eprosartan Mesylate Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Abbott
12.1.1 Abbott Corporation Information
12.1.2 Abbott Overview
12.1.3 Abbott Eprosartan Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Abbott Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Abbott Recent Developments
12.2 Viatris (Mylan)
12.2.1 Viatris (Mylan) Corporation Information
12.2.2 Viatris (Mylan) Overview
12.2.3 Viatris (Mylan) Eprosartan Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Viatris (Mylan) Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Viatris (Mylan) Recent Developments
12.3 The United States Pharmacopeial Convention
12.3.1 The United States Pharmacopeial Convention Corporation Information
12.3.2 The United States Pharmacopeial Convention Overview
12.3.3 The United States Pharmacopeial Convention Eprosartan Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 The United States Pharmacopeial Convention Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 The United States Pharmacopeial Convention Recent Developments
12.4 Unichem Laboratories
12.4.1 Unichem Laboratories Corporation Information
12.4.2 Unichem Laboratories Overview
12.4.3 Unichem Laboratories Eprosartan Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Unichem Laboratories Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Unichem Laboratories Recent Developments
12.5 Jubilant Generics
12.5.1 Jubilant Generics Corporation Information
12.5.2 Jubilant Generics Overview
12.5.3 Jubilant Generics Eprosartan Mesylate Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Jubilant Generics Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Jubilant Generics Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Eprosartan Mesylate Industry Chain Analysis
13.2 Eprosartan Mesylate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Eprosartan Mesylate Production Mode & Process
13.4 Eprosartan Mesylate Sales and Marketing
13.4.1 Eprosartan Mesylate Sales Channels
13.4.2 Eprosartan Mesylate Distributors
13.5 Eprosartan Mesylate Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Eprosartan Mesylate Industry Trends
14.2 Eprosartan Mesylate Market Drivers
14.3 Eprosartan Mesylate Market Challenges
14.4 Eprosartan Mesylate Market Restraints
15 Key Finding in The Global Eprosartan Mesylate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Eprosartan Mesylate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 200mg
Table 3. Major Manufacturers of 400mg
Table 4. Global Eprosartan Mesylate Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Eprosartan Mesylate Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Eprosartan Mesylate Production by Region (2017-2022) & (Tons)
Table 7. Global Eprosartan Mesylate Production Market Share by Region (2017-2022)
Table 8. Global Eprosartan Mesylate Production by Region (2023-2028) & (Tons)
Table 9. Global Eprosartan Mesylate Production Market Share by Region (2023-2028)
Table 10. Global Eprosartan Mesylate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Eprosartan Mesylate Sales by Region (2017-2022) & (Tons)
Table 12. Global Eprosartan Mesylate Sales Market Share by Region (2017-2022)
Table 13. Global Eprosartan Mesylate Sales by Region (2023-2028) & (Tons)
Table 14. Global Eprosartan Mesylate Sales Market Share by Region (2023-2028)
Table 15. Global Eprosartan Mesylate Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Eprosartan Mesylate Revenue Market Share by Region (2017-2022)
Table 17. Global Eprosartan Mesylate Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Eprosartan Mesylate Revenue Market Share by Region (2023-2028)
Table 19. Global Eprosartan Mesylate Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Eprosartan Mesylate Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Eprosartan Mesylate Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Eprosartan Mesylate Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Eprosartan Mesylate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Eprosartan Mesylate Revenue Share by Manufacturers (2017-2022)
Table 25. Eprosartan Mesylate Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Eprosartan Mesylate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Eprosartan Mesylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eprosartan Mesylate as of 2021)
Table 28. Eprosartan Mesylate Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Eprosartan Mesylate Product Offered
Table 30. Date of Manufacturers Enter into Eprosartan Mesylate Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Eprosartan Mesylate Sales by Type (2017-2022) & (Tons)
Table 33. Global Eprosartan Mesylate Sales by Type (2023-2028) & (Tons)
Table 34. Global Eprosartan Mesylate Sales Share by Type (2017-2022)
Table 35. Global Eprosartan Mesylate Sales Share by Type (2023-2028)
Table 36. Global Eprosartan Mesylate Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Eprosartan Mesylate Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Eprosartan Mesylate Revenue Share by Type (2017-2022)
Table 39. Global Eprosartan Mesylate Revenue Share by Type (2023-2028)
Table 40. Eprosartan Mesylate Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Eprosartan Mesylate Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Eprosartan Mesylate Sales by Application (2017-2022) & (Tons)
Table 43. Global Eprosartan Mesylate Sales by Application (2023-2028) & (Tons)
Table 44. Global Eprosartan Mesylate Sales Share by Application (2017-2022)
Table 45. Global Eprosartan Mesylate Sales Share by Application (2023-2028)
Table 46. Global Eprosartan Mesylate Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Eprosartan Mesylate Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Eprosartan Mesylate Revenue Share by Application (2017-2022)
Table 49. Global Eprosartan Mesylate Revenue Share by Application (2023-2028)
Table 50. Eprosartan Mesylate Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Eprosartan Mesylate Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Eprosartan Mesylate Sales by Type (2017-2022) & (Tons)
Table 53. North America Eprosartan Mesylate Sales by Type (2023-2028) & (Tons)
Table 54. North America Eprosartan Mesylate Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Eprosartan Mesylate Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Eprosartan Mesylate Sales by Application (2017-2022) & (Tons)
Table 57. North America Eprosartan Mesylate Sales by Application (2023-2028) & (Tons)
Table 58. North America Eprosartan Mesylate Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Eprosartan Mesylate Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Eprosartan Mesylate Sales by Country (2017-2022) & (Tons)
Table 61. North America Eprosartan Mesylate Sales by Country (2023-2028) & (Tons)
Table 62. North America Eprosartan Mesylate Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Eprosartan Mesylate Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Eprosartan Mesylate Sales by Type (2017-2022) & (Tons)
Table 65. Europe Eprosartan Mesylate Sales by Type (2023-2028) & (Tons)
Table 66. Europe Eprosartan Mesylate Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Eprosartan Mesylate Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Eprosartan Mesylate Sales by Application (2017-2022) & (Tons)
Table 69. Europe Eprosartan Mesylate Sales by Application (2023-2028) & (Tons)
Table 70. Europe Eprosartan Mesylate Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Eprosartan Mesylate Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Eprosartan Mesylate Sales by Country (2017-2022) & (Tons)
Table 73. Europe Eprosartan Mesylate Sales by Country (2023-2028) & (Tons)
Table 74. Europe Eprosartan Mesylate Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Eprosartan Mesylate Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Eprosartan Mesylate Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Eprosartan Mesylate Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Eprosartan Mesylate Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Eprosartan Mesylate Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Eprosartan Mesylate Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Eprosartan Mesylate Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Eprosartan Mesylate Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Eprosartan Mesylate Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Eprosartan Mesylate Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Eprosartan Mesylate Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Eprosartan Mesylate Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Eprosartan Mesylate Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Eprosartan Mesylate Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Eprosartan Mesylate Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Eprosartan Mesylate Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Eprosartan Mesylate Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Eprosartan Mesylate Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Eprosartan Mesylate Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Eprosartan Mesylate Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Eprosartan Mesylate Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Eprosartan Mesylate Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Eprosartan Mesylate Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Eprosartan Mesylate Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Eprosartan Mesylate Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Eprosartan Mesylate Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Eprosartan Mesylate Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Eprosartan Mesylate Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Eprosartan Mesylate Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Eprosartan Mesylate Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Eprosartan Mesylate Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Eprosartan Mesylate Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Eprosartan Mesylate Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Eprosartan Mesylate Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Eprosartan Mesylate Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Eprosartan Mesylate Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Eprosartan Mesylate Revenue by Country (2023-2028) & (US$ Million)
Table 112. Abbott Corporation Information
Table 113. Abbott Description and Major Businesses
Table 114. Abbott Eprosartan Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Abbott Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Abbott Recent Development
Table 117. Viatris (Mylan) Corporation Information
Table 118. Viatris (Mylan) Description and Major Businesses
Table 119. Viatris (Mylan) Eprosartan Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Viatris (Mylan) Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Viatris (Mylan) Recent Development
Table 122. The United States Pharmacopeial Convention Corporation Information
Table 123. The United States Pharmacopeial Convention Description and Major Businesses
Table 124. The United States Pharmacopeial Convention Eprosartan Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. The United States Pharmacopeial Convention Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. The United States Pharmacopeial Convention Recent Development
Table 127. Unichem Laboratories Corporation Information
Table 128. Unichem Laboratories Description and Major Businesses
Table 129. Unichem Laboratories Eprosartan Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 130. Unichem Laboratories Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Unichem Laboratories Recent Development
Table 132. Jubilant Generics Corporation Information
Table 133. Jubilant Generics Description and Major Businesses
Table 134. Jubilant Generics Eprosartan Mesylate Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 135. Jubilant Generics Eprosartan Mesylate Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Jubilant Generics Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Eprosartan Mesylate Distributors List
Table 140. Eprosartan Mesylate Customers List
Table 141. Eprosartan Mesylate Market Trends
Table 142. Eprosartan Mesylate Market Drivers
Table 143. Eprosartan Mesylate Market Challenges
Table 144. Eprosartan Mesylate Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Eprosartan Mesylate Product Picture
Figure 2. Global Eprosartan Mesylate Market Share by Type in 2021 & 2028
Figure 3. 200mg Product Picture
Figure 4. 400mg Product Picture
Figure 5. Global Eprosartan Mesylate Market Share by Application in 2021 & 2028
Figure 6. Hypertension Diagnosis
Figure 7. Heart Failure Diagnosis
Figure 8. Others
Figure 9. Eprosartan Mesylate Report Years Considered
Figure 10. Global Eprosartan Mesylate Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 11. Global Eprosartan Mesylate Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Eprosartan Mesylate Production Market Share by Region (2017-2022)
Figure 13. Global Eprosartan Mesylate Production Market Share by Region (2023-2028)
Figure 14. Eprosartan Mesylate Production Growth Rate in North America (2017-2028) & (Tons)
Figure 15. Eprosartan Mesylate Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 16. Eprosartan Mesylate Production Growth Rate in China (2017-2028) & (Tons)
Figure 17. Eprosartan Mesylate Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 18. Global Eprosartan Mesylate Sales 2017-2028 (Tons)
Figure 19. Global Eprosartan Mesylate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Eprosartan Mesylate Revenue 2017-2028 (US$ Million)
Figure 21. Global Eprosartan Mesylate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Eprosartan Mesylate Sales Market Share by Region (2017-2022)
Figure 23. Global Eprosartan Mesylate Sales Market Share by Region (2023-2028)
Figure 24. North America Eprosartan Mesylate Sales YoY (2017-2028) & (Tons)
Figure 25. North America Eprosartan Mesylate Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Eprosartan Mesylate Sales YoY (2017-2028) & (Tons)
Figure 27. Europe Eprosartan Mesylate Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Eprosartan Mesylate Sales YoY (2017-2028) & (Tons)
Figure 29. Asia-Pacific Eprosartan Mesylate Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Eprosartan Mesylate Sales YoY (2017-2028) & (Tons)
Figure 31. Latin America Eprosartan Mesylate Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Eprosartan Mesylate Sales YoY (2017-2028) & (Tons)
Figure 33. Middle East & Africa Eprosartan Mesylate Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Eprosartan Mesylate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Eprosartan Mesylate in the World: Market Share by Eprosartan Mesylate Revenue in 2021
Figure 36. Eprosartan Mesylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Eprosartan Mesylate Sales Market Share by Type (2017-2028)
Figure 38. Global Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
Figure 39. Global Eprosartan Mesylate Sales Market Share by Application (2017-2028)
Figure 40. Global Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
Figure 41. North America Eprosartan Mesylate Sales Market Share by Type (2017-2028)
Figure 42. North America Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
Figure 43. North America Eprosartan Mesylate Sales Market Share by Application (2017-2028)
Figure 44. North America Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
Figure 45. North America Eprosartan Mesylate Sales Share by Country (2017-2028)
Figure 46. North America Eprosartan Mesylate Revenue Share by Country (2017-2028)
Figure 47. United States Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Eprosartan Mesylate Sales Market Share by Type (2017-2028)
Figure 50. Europe Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
Figure 51. Europe Eprosartan Mesylate Sales Market Share by Application (2017-2028)
Figure 52. Europe Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
Figure 53. Europe Eprosartan Mesylate Sales Share by Country (2017-2028)
Figure 54. Europe Eprosartan Mesylate Revenue Share by Country (2017-2028)
Figure 55. Germany Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 56. France Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Eprosartan Mesylate Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Eprosartan Mesylate Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Eprosartan Mesylate Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Eprosartan Mesylate Revenue Share by Region (2017-2028)
Figure 66. China Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 69. India Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 71. China Taiwan Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Eprosartan Mesylate Sales Market Share by Type (2017-2028)
Figure 76. Latin America Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Eprosartan Mesylate Sales Market Share by Application (2017-2028)
Figure 78. Latin America Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Eprosartan Mesylate Sales Share by Country (2017-2028)
Figure 80. Latin America Eprosartan Mesylate Revenue Share by Country (2017-2028)
Figure 81. Mexico Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 84. Colombia Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Eprosartan Mesylate Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Eprosartan Mesylate Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Eprosartan Mesylate Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Eprosartan Mesylate Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Eprosartan Mesylate Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Eprosartan Mesylate Revenue Share by Country (2017-2028)
Figure 91. Turkey Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 93. UAE Eprosartan Mesylate Revenue (2017-2028) & (US$ Million)
Figure 94. Eprosartan Mesylate Value Chain
Figure 95. Eprosartan Mesylate Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

---